1. A multivariable prediction model for pegvisomant dosing: monotherapy and in combination with long-acting somatostatin analogues. Issue 4 (April 2017) Authors: Franck, S E; Korevaar, T I M; Petrossians, P; Daly, A F; Chanson, P; Jaffrain-Réa, M L; Brue, T; Stalla, G K; Carvalho, D; Colao, A; Hána, V; Delemer, B; Fajardo, C; van der Lely, A J; Beckers, A; Neggers, S J C M M Journal: European journal of endocrinology Issue: Volume 176:Issue 4(2017) Page Start: 421 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Hypothalamic–pituitary–adrenal axis stress test in patients with early RA: role of corticotropin-releasing hormone promoter polymorphisms. Issue 11 (10th June 2011) Authors: Malysheva, O; Wagner, U; Wahle, M; Pierer, M; Wagner, U; Stalla, G K; Baerwald, C G O Journal: Annals of the rheumatic diseases Issue: Volume 70:Issue 11(2011) Page Start: 2058 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Neuropsychiatric and cardiometabolic comorbidities in patients with previously diagnosed Cushing's disease: a longitudinal observational study. Issue 3 (27th March 2015) Authors: Dimopoulou, C; Geraedts, V; Stalla, G K; Sievers, C Journal: BMJ open Issue: Volume 5:Issue 3(2015) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Protein stabilization by RSUME accounts for PTTG pituitary tumor abundance and oncogenicity. Issue 6 (June 2018) Authors: Fuertes, M; Sapochnik, M; Tedesco, L; Senin, S; Attorresi, A; Ajler, P; Carrizo, G; Cervio, A; Sevlever, G; Bonfiglio, J J; Stalla, G K; Arzt, E Journal: Endocrine-related cancer Issue: Volume 25:Issue 6(2018) Page Start: 665 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗